KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查

Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.

Okasha Zulfiqar, Talha Ali, Ghulam Mohayy Ud Din, Zaheer Ud Din Babar, Shabir Zarif

Cureus 18(5) e109528

PMID42344814
PMCIDPMC13287821
DOI10.7759/cureus.109528
发表日期2026-06-25
AI 判定该论文不进入自动 KM 提取:This is a systematic review of multiple phase 3 trials, not a primary report of a single phase 3 randomized controlled trial.
摘要

摘要

This systematic review evaluates the comparative efficacy and safety of oral small-molecule therapies and biologic agents in adults with moderate-to-severe ulcerative colitis (UC). Evidence from eight landmark publications encompassing multiple pivotal phase 3 randomized controlled trials was synthesized to assess induction and maintenance outcomes across distinct therapeutic mechanisms, including intracellular cytokine signaling inhibition, immune trafficking modulation, and extracellular pathway blockade. The findings suggest that oral small-molecule therapies demonstrate clinically meaningful efficacy comparable to established biologic agents while offering practical advantages related to oral administration and mechanistic diversity. Distinct differences in induction and maintenance performance across therapeutic classes highlight the importance of goal-directed therapy selection, individualized risk stratification, and mechanism-based treatment sequencing rather than class cycling alone. Overall, this review underscores the evolving role of oral therapies as integral components of contemporary UC management while emphasizing the need to balance efficacy, safety considerations, and patient-centered treatment priorities.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。